Back

What is current guideline-recommended medical therapy for HFrEF?

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HFrEF treatment: where are we and where are we going? Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)

4 More presentations in this session

Presentation thumbnail
How should we best optimise therapy for HFrEF?
Professor M. Arrigo (Lugano, CH)
Slides Video
Presentation thumbnail
When should we downtitrate or stop HFrEF therapy?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
What is on the horizon for HFrEF therapy?
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
HFrEF treatment: where are we and where are we going? - discussion
Video

Access the full session

Session thumbnail
HFrEF treatment: where are we and where are we going?
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Guidelines in clinical practice
thumbnail
Congress Session
HFrEF treatment: where are we and where are we going?
thumbnail
Congress Session
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – Ask the Guidelines Task Force

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources